2N8F
Chemical shift assignments and structure calculation of spider toxin pi-hexatoxin-Hi1a
2N8F の概要
| エントリーDOI | 10.2210/pdb2n8f/pdb |
| NMR情報 | BMRB: 25848 |
| 分子名称 | spider toxin pi-hexatoxin-Hi1a (1 entity in total) |
| 機能のキーワード | spider toxin, inhibitor cystine knot, double knot toxin, asic1a antagonist, ion channel modulator, toxin |
| 由来する生物種 | Hadronyche infensa |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 8750.20 |
| 構造登録者 | Chin, Y.K.-Y.,Pineda, S.S.,Mobli, M.,King, G.F. (登録日: 2015-10-13, 公開日: 2016-10-19, 最終更新日: 2024-11-27) |
| 主引用文献 | Chassagnon, I.R.,McCarthy, C.A.,Chin, Y.K.,Pineda, S.S.,Keramidas, A.,Mobli, M.,Pham, V.,De Silva, T.M.,Lynch, J.W.,Widdop, R.E.,Rash, L.D.,King, G.F. Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. Proc. Natl. Acad. Sci. U.S.A., 114:3750-3755, 2017 Cited by PubMed Abstract: Stroke is the second-leading cause of death worldwide, yet there are no drugs available to protect the brain from stroke-induced neuronal injury. Acid-sensing ion channel 1a (ASIC1a) is the primary acid sensor in mammalian brain and a key mediator of acidosis-induced neuronal damage following cerebral ischemia. Genetic ablation and selective pharmacologic inhibition of ASIC1a reduces neuronal death following ischemic stroke in rodents. Here, we demonstrate that Hi1a, a disulfide-rich spider venom peptide, is highly neuroprotective in a focal model of ischemic stroke. Nuclear magnetic resonance structural studies reveal that Hi1a comprises two homologous inhibitor cystine knot domains separated by a short, structurally well-defined linker. In contrast with known ASIC1a inhibitors, Hi1a incompletely inhibits ASIC1a activation in a pH-independent and slowly reversible manner. Whole-cell, macropatch, and single-channel electrophysiological recordings indicate that Hi1a binds to and stabilizes the closed state of the channel, thereby impeding the transition into a conducting state. Intracerebroventricular administration to rats of a single small dose of Hi1a (2 ng/kg) up to 8 h after stroke induction by occlusion of the middle cerebral artery markedly reduced infarct size, and this correlated with improved neurological and motor function, as well as with preservation of neuronal architecture. Thus, Hi1a is a powerful pharmacological tool for probing the role of ASIC1a in acid-mediated neuronal injury and various neurological disorders, and a promising lead for the development of therapeutics to protect the brain from ischemic injury. PubMed: 28320941DOI: 10.1073/pnas.1614728114 主引用文献が同じPDBエントリー |
| 実験手法 | SOLUTION NMR |
構造検証レポート
検証レポート(詳細版)
をダウンロード






